We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ocular Therapeutix Inc | NASDAQ:OCUL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.06 | -1.25% | 4.74 | 4.60 | 4.84 | 4.995 | 4.6201 | 4.72 | 2,000,147 | 01:00:00 |
The Klein Law Firm announces the commencement of an investigation of Ocular Therapeutix, Inc. (NASDAQ:OCUL) concerning possible violations of federal securities laws.
On May 5, 2017, Ocular Therapeutix disclosed that the U.S. Food and Drug Administration had found minor issues at its manufacturing plant. However, on July 6, 2017, an article published by Seeking Alpha claimed that Ocular Therapeutix’s management had been misleading investors about manufacturing issues. One of the claims made by the article is that more than 50% of lots manufactured by Ocular Therapeutix contain bad product. Following this news, the price of Ocular Therapeutix shares fell $0.68 per share or over 6% to close at $9.50 per share on July 6, 2017.
If you suffered a loss in Ocular Therapeutix and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kkclasslaw.com/OCUL-Info-Request-Form-176.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170717006072/en/
The Klein Law FirmJoseph Klein, Esq., (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.com
1 Year Ocular Therapeutix Chart |
1 Month Ocular Therapeutix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions